We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Dr. Miravitlles’ career was recognized during the 57th edition of the SEPAR National Congress held in Valencia.
The Spanish Society of Pneumology and Thoracic Surgery (SEPAR) brings together nearly 6,000 specialists in this field. Its main objective is to promote research, training and the dissemination of information on respiratory diseases, which are one of the main causes of death in Europe.
Recently, the 57th edition of the SEPAR National Congress took place. This event is the most important scientific meeting on respiratory diseases held in Spanish and is a unique opportunity to learn about the latest advances in the prevention and treatment of respiratory diseases. It also hosts the Manuel Tapia Conference, a plenary conference named in honour of one of the most prominent figures in 20th century pneumology and the founder of SEPAR. Each year, an internationally renowned pulmonologist is invited to give a lecture in recognition of his or her research career.
In 2024, the guest was Dr Marc Miravitlles, a specialist in pneumology at the Vall d'Hebron University Hospital and a researcher in the Pneumology group at the Vall d'Hebron Research Institute (VHIR). Miravitlles used the lecture to discuss the main milestones of his professional career at Vall d'Hebron in the field of chronic obstructive pulmonary disease (COPD) and alpha-1 antitrypsin deficiency (AATD). This includes the coordination of the three most important national epidemiological studies on COPD and the Spanish clinical practice guideline for the treatment of COPD. He was also a pioneer in the treatment of AATD, founder of the Spanish AATD registry and coordinator of the European clinical guideline for the treatment of AATD and the world's largest AATD registry from the VHIR.
In keeping with tradition, Miravitlles was made an honorary member of SEPAR at this key event, an honour that had previously been bestowed on only one other researcher from Vall d'Hebron, Dr Ferran Morell Brotad.
Pneumology, General Hospital
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.